US3244180A - Smoking article combination - Google Patents
Smoking article combination Download PDFInfo
- Publication number
- US3244180A US3244180A US381091A US38109164A US3244180A US 3244180 A US3244180 A US 3244180A US 381091 A US381091 A US 381091A US 38109164 A US38109164 A US 38109164A US 3244180 A US3244180 A US 3244180A
- Authority
- US
- United States
- Prior art keywords
- ascorbic acid
- smoking
- cigarette
- tobacco
- edible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000391 smoking effect Effects 0.000 title claims description 21
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 114
- 235000010323 ascorbic acid Nutrition 0.000 claims description 55
- 239000011668 ascorbic acid Substances 0.000 claims description 55
- 229960005070 ascorbic acid Drugs 0.000 claims description 55
- 235000019505 tobacco product Nutrition 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 11
- 235000019504 cigarettes Nutrition 0.000 description 30
- 241000208125 Nicotiana Species 0.000 description 21
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 21
- 239000000779 smoke Substances 0.000 description 19
- 210000001519 tissue Anatomy 0.000 description 8
- 239000000470 constituent Substances 0.000 description 6
- 239000008187 granular material Substances 0.000 description 5
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 4
- 206010047623 Vitamin C deficiency Diseases 0.000 description 4
- 235000019506 cigar Nutrition 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 4
- 229960002715 nicotine Drugs 0.000 description 4
- 208000010233 scurvy Diseases 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000001066 destructive effect Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 201000005202 lung cancer Diseases 0.000 description 3
- 208000020816 lung neoplasm Diseases 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001473 noxious effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 150000000996 L-ascorbic acids Chemical class 0.000 description 2
- 239000000729 antidote Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000037058 blood plasma level Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000002561 chemical irritant Substances 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 230000036325 urinary excretion Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F47/00—Smokers' requisites not otherwise provided for
Definitions
- This invention relates to an improved construct-ion of smoking articles containing a means for counteracting the noxious effects of tobacco smoke on the human body. It has for one of its important objects the provision of a convenient means of supplying an antidote to the toxic effects of tobacco smoke and also a means for insuring that the antidote is consumed before the tobacco is smoked.
- tobacco smoke has many other systemic effects on the body.
- the toxic alkaloid, nicotine a constituent of all tobacco smoke has a direct poisonous reaction in the body in minute amounts. This accounts for many of the toxic disturbances exhibited by new smokers who have not had time to build up a bodily immunity or tolerance to the toxic doses of nicotine in the tobacco smoke.
- Vitamin C or ascorbic acid is the essential vitamin whose lack in the diet causes the sometimes fatal disease, scurvy. Vitamin C will be referred to hereafter as ascorbic acid.
- Ascorbic acid is very important and biochemically essential for the normal metabolism of the body. In addition to its protective and curavtive efiects in scurvy, it is vital for the maintenance of the health and integrity 3,244,186 Patented Apr. 5, 1966 of all the tissues. Its presence is required in many essential metabolic processes among which are the resistance to disease and infections and in the detoxification of many poisonous substances that the body absorbs by contact, inhalation or ingestion.
- Ascorbic acid is not stored to any extent by the body, making its continued daily ingestion a necessity for good health.
- the National Research Council recommends the daily intake of to milligrams of ascorbic acid. Complete deprivation results in death from scurvy in a comparatively short space of time. If the intake of ascorbic acid is sub-marginal or the ingested amount is largely destroyed by tobacco smoke or other exogenous toxins or stresses, symptoms of frank scurvy may not develop but the prescorbutic state will exist.
- Venulet (Medizinische Klin., 49: 959-962, 1954) showed similar results on tests with animals, he also discusses the various organs weakened by the losses of ascorbic acid. McCormick (Archives of Pediatrics, 69: 151-155, 1952) discusses the ability of ascorbic acid to neutralize toxins of exogenous orgin and states that he has determined by labaratory and clinical tests that the smoking of one cigarette neutralizes in the body approximately 25 milligrams of ascorbic acid, or the amount in one medium-sized orange.
- collagenous tissue is wholly dependent upon ascorbic acid.
- the body is unable to synthesize collagen in tissues depleted of ascorbic acid.
- Collagen is the groundwork or cementing substance that holds the cells of a tissue together and intact. If the collagen is weakened or lacking in the ascorbic acid depleted state, any primary cancerous lesion that may form in the lung or upper respiratory tract will readily metastasize and break away and spread to other parts of the body because the normal restraint of a firm collagenous cementing network surrounding and holding the cells together will be lacking.
- the increase in the incidence of lung cancer due to the increase in smoking cigarettes may be nothing more than a physiological response of the body to a long continued state of ascorbic acid depletion combined with the insults of chronic exposure to inhaled chemical irritants of tobacco smoke.
- My invention is a direct attack on this problem by supplying ascorbic acid to the smoker in a readily available and pleasant form to replace that destroyed by the tobacco smoke.
- Another object of the invention is that the ascorbic acid is a part of the smoking article so that the amount of ascorbic acid consumed by the smoker is in direct relation to the number of cigarettes smoked.
- a most important object of my invention is that the smoker cannot fail to remember to take this ascorbic acid supplementation before smoking the cigarette, cigar or other smoking article because the particular construction of the combination makes it necessary to remove the as corbic acid-containing material before the article can be smoked.
- FIGURE 1 is a side view of a cigarette, partly in section and showing the invention as applied to a recessed filter cigarette.
- FIGURE 2 is a view similar to FIGURE 1 but illustrating a form of the invention applied to a non-recessed filter cigarette or a non-filter cigarette or cigar.
- FIGURE 3 is a view similar to FIG- URE 1, but showing an edible tablet inserted in the end of a filter (or non-filter) cigarette.
- FIGURE 4 is a view similar to FIGURE 1, but showing an edible tablet inserted in the end of a recessed filter cigarette.
- FIGURE 5 is a view similar to FIGURE 1, but showing a recessed filter cigarette with the end stuffed with an edible ascorbic acid fluff.
- FIGURE 6 is a view similar to FIGURE 1, but showing a still further modification.
- FIGURE 1 there is shown the invention as applied to a recessed filter type cigarette.
- the outside membrane, 10, forms the wall of the cigarette; the recessed filter, 11, defines a cavity at the end of said cigarette.
- This cavity contains granules of a pharmaceutical confection contain ing ascorbic acid.
- the ascorbic acid containing material, 12, is a palatable mixture which may be prepared by mixing ascorbic acid and a sweetening agent such as sugar or synthetic sweeteners. If necessary to increase the bulk and aid in granulation of the powders, some inert filling material such as mannitol may be added. This mixture is granulated to obtain the free-flowing dry granules which being water soluble, will dissolve readily in the saliva when taken into the mouth.
- a snug cover, 13, retains the granules in the cavity.
- cover, 13 is removed and the cigarette end is inverted into the mouth to permit the granules to fall upon the tongue. After dissolution in the saliva it is then swallowed. The cigarette is then smoked in the normal manner.
- FIGURE 2 there is shown another embodiment of the invention suitable for cigarettes or cigars.
- the figure shows a cigarette with the month end covered or capped with a removable cover, 17.
- This cover is prepared from an edible sheet material containing the desired dosage of ascorbic acid. It may also contain sweetening or flavoring agents to make the ingestion of the edible sheet material more palatable.
- the edible sheet material can be prepared by drying a solution of an edible film forming agent such as carboxy methyl cellulose or other water soluble gums or polyvinylpyrrolidone or proteinaceous film forming materials like egg albumen, soluble caseinor mixtures thereof.
- the ascorbic acid may be dissolved in the solution of the film forming agent before drying on a fiat surface to obtain the soluble, edible, ascorbic acid-containing sheet material.
- the smoker removes the edible cover, 17, and allows it to dissolve in the mouth and in this Way imbibes the requisite dosage of ascorbic acid.
- the cigarette or cigar may then be smoked in the usual fashion.
- FIGURES 3 and 4 there are illustrated cigarettes constructed to accommodate a shaped tablet containing the proper dosage of ascorbic acid and any flavoring or sweetening agents to make them more palatable.
- the tablet, 30, is inserted into the mouth end of a filter cigarette by means of the inwardly projecting tip, 32.
- the shaped tablet, 49 is fitted like a plug into the cavity, 4 1, formed at the mouth end of a recessed filter cigarette, 42.
- the smoker removes the tablet from the cigarette with his teeth or lips and either chews or lets the tablet dissolve in his mouth. The cigarette is then lit and smoked as usual.
- FIGURE 5 shows the application of edible filamentous fiufi? material containing ascorbic acid in conjunction with a recessed filter type cigarette.
- This ascorbic acid-containing fluff, 50 which is stuffed into the cavity, 511, at the recessed filter end of the cigarette, 52.
- This fluff is prepared by the centrifugal methods commonly used to prepare cotton candy. The smoker merely snags the ascorbic acid flufi? with his teeth and removes it to his mouth where it dissolves and is swallowed. In this Way he replaces the ascorbic acid that will be lost during smoking.
- FIGURE 6 there is shown a filter cigarette, 60, with a cavity, 6 1, in the filter which may be filled with ascorbic acid-containing granules as in FIGURE 1 or ascorbic acid containing fluff as in FIGURE 5 or with an ascorbic acidcontaining tablet as in FIGURE 4.
- An improved elongated smokable tobacco product comprising a cylindrical body of tobacco having a caplike member surrounding at least one end thereof and in slideable engagement therewith, said cap-like member being formed of an edible, water-soluble sheet-forming material containing a mass of ascorbic acid at least equal in Weight to the amount of ascorbic acid lost in the human body in the smoking of said tobacco product.
- a mass of ascorbic acid at least equal in weight to the amount of ascorbic acid lost by the human body in smoking said tobacco product, located adjacent one end thereof and means connecting said mass of ascorbic acid to said tobacco product in such a way that said mass may be removed from said tobacco product without destruction thereof, said mass of ascorbic acid and its connecting means completely obstructing one end of said tobacco product, said means for connecting said ascorbic acid to said tobacco product comprising an edible sheath surrouding one end of said tobacco product and said mass of ascorbic acid being disposed within said sheath.
- An elongated smoking tobacco product comprising a tubular casing enclosing a charge of smoking tobacco, said tubular casing extending at one end past said charge of tobacco whereby a recess is formed in said end, a solid cylindrical tablet located in said recess in frictional engagement with the walls thereof substantially obstructing said end and extending outwardly from the end of said recess in such manner that its removal before smoking said tobacco product is facilitated; said tablet being edible and comprising a mass of ascorbic acid at least equal in weight 5 6 to the amount of ascorbic acid lost by the human body FOREIGN PATENTS in smoking said tobacco product.
Landscapes
- Manufacture Of Tobacco Products (AREA)
Description
April 5, 1966 B. STONE 3,244,180
-SMOKING ARTICLE COMBINATION Original Filed Aug. 27, 1962 INVENTOR. BARBARA 5TONE United States Patent 3,244,180 SMOKING ARTICLE COMBINATION Barbara Stone, 208 Winchester Ave., Staten Island, N.Y. 10312 Continuation of application Ser. No. 219,503, Aug. 27, 1962. This application July 8, 1964, Ser. No. 381,091 3 Claims. (Cl. 131-4) This application is a continuation of my application Serial No. 219,503, filed August 27, 1962, now abandoned.
This invention relates to an improved construct-ion of smoking articles containing a means for counteracting the noxious effects of tobacco smoke on the human body. It has for one of its important objects the provision of a convenient means of supplying an antidote to the toxic effects of tobacco smoke and also a means for insuring that the antidote is consumed before the tobacco is smoked.
The consumption of cigarettes has increased enormously in the past decades. There has been a parallel increase in the incidence of lung cancer among the population. Recent studies have shown that the incidence of lung cancer is much higher in smokers than in nonsmokers. Even after many studies have brought out the dangers consequent to the smoking of cigarettes, the consumption of cigarettes has continued to rise in greater and greater volume.
Studies have shown that tobacco smoke contains carcinogenic constituents which when inhaled deposit on the delicate lung tissue and membranes, set up irritation which on long continued action start the foci for the development of cancerous growths.
In addition to this direct contact irritation of the lung tissues, tobacco smoke has many other systemic effects on the body. For instance, the toxic alkaloid, nicotine, a constituent of all tobacco smoke has a direct poisonous reaction in the body in minute amounts. This accounts for many of the toxic disturbances exhibited by new smokers who have not had time to build up a bodily immunity or tolerance to the toxic doses of nicotine in the tobacco smoke.
Other noxious constituents of the smoke besides nicotine also exert undesirable systemic effects on the body. Profound changes in the vascular system and other organs of the body are caused by tobacco smoke. A very important effect on the body chemistry, causing far-reaching consequences, is the destructive properties of tobacco smoke on the vitamin content of the body. Tobacco smoke and its constituents have a destructive action on vitamin C both in vitro and in vivo.
Vitamin C or ascorbic acid is the essential vitamin whose lack in the diet causes the sometimes fatal disease, scurvy. Vitamin C will be referred to hereafter as ascorbic acid.
This destruction of ascorbic acid by tobacco smoke causes a depletion of the ascorbic acid reserves of the body in heavy smokers, bringing with it the attendant symptoms of the deficiency state such as a lowered resistance to disease and the inability of the body to successfully cope with and combat the toxic manifestations of the noxious chemicals contained in the tobacco smoke.
Ascorbic acid is very important and biochemically essential for the normal metabolism of the body. In addition to its protective and curavtive efiects in scurvy, it is vital for the maintenance of the health and integrity 3,244,186 Patented Apr. 5, 1966 of all the tissues. Its presence is required in many essential metabolic processes among which are the resistance to disease and infections and in the detoxification of many poisonous substances that the body absorbs by contact, inhalation or ingestion.
Ascorbic acid is not stored to any extent by the body, making its continued daily ingestion a necessity for good health. The National Research Council recommends the daily intake of to milligrams of ascorbic acid. Complete deprivation results in death from scurvy in a comparatively short space of time. If the intake of ascorbic acid is sub-marginal or the ingested amount is largely destroyed by tobacco smoke or other exogenous toxins or stresses, symptoms of frank scurvy may not develop but the prescorbutic state will exist. In this state the bodys biochemical metabolism is operating under sub-optimal conditions and its victims have a general feeling of lassitude and not feeling just right and have a greatly lowered resistance to the infectious diseases and exogenous toxins and the inability to cope with the many stresses of living including smoking.
There are many papers in the scientific literature showing the destructive effect of tobacco smoke and its constituents on ascorbic acid. Bourquin and Musmanno (American Journal of Digestive Diseases, 20: 75-77, 1953) in experiments on humans showed a drop in the blood ascorbic acid levels due to smoking. In vitro experiments on human blood showed a destruction of its ascorbic acid content by nicotine. Similar drops in the blood plasma levels of ascorbic acid in smokers was shown by Dietrich and Buchner (Deutsche Gesundheitwesen, 15: 2494-2495, 1960). They also showed a decrease in urinary excretion of ascorbic acid in smokers which indicated a destruction of the ascorbic acid by the smoke. Venulet (Medizinische Klin., 49: 959-962, 1954) showed similar results on tests with animals, he also discusses the various organs weakened by the losses of ascorbic acid. McCormick (Archives of Pediatrics, 69: 151-155, 1952) discusses the ability of ascorbic acid to neutralize toxins of exogenous orgin and states that he has determined by labaratory and clinical tests that the smoking of one cigarette neutralizes in the body approximately 25 milligrams of ascorbic acid, or the amount in one medium-sized orange.
Based on this work of McCormick it is easy to calculate that a pack-a-day smoker will destroy approximately 500 milligrams of his bodys ascorbic acid. It is not surprising, therefore, that most heavy smokers are in a chronic state of sub-marginal ascorbic acid nutriture and are thus exposed to all the hazards of the preascorbutic state.
It is my belief and the belief of others that this chronic state of ascorbic acid depletion is responsible for many of the deleterious manifestations of smoking. The depleted tissues and membranes of the respiratory tract have lowered resistance to the irritating constituents of tobacco smoke. T-his lowered resistance over long periods of exposure may possibly predispose these tissues to the development of cancerous foci from the carcinogenic agents in the tobacco smoke.
Further, the integrity of the collagenous tissue is wholly dependent upon ascorbic acid. The body is unable to synthesize collagen in tissues depleted of ascorbic acid. Collagen is the groundwork or cementing substance that holds the cells of a tissue together and intact. If the collagen is weakened or lacking in the ascorbic acid depleted state, any primary cancerous lesion that may form in the lung or upper respiratory tract will readily metastasize and break away and spread to other parts of the body because the normal restraint of a firm collagenous cementing network surrounding and holding the cells together will be lacking.
The increase in the incidence of lung cancer due to the increase in smoking cigarettes may be nothing more than a physiological response of the body to a long continued state of ascorbic acid depletion combined with the insults of chronic exposure to inhaled chemical irritants of tobacco smoke.
My invention is a direct attack on this problem by supplying ascorbic acid to the smoker in a readily available and pleasant form to replace that destroyed by the tobacco smoke.
Another object of the invention is that the ascorbic acid is a part of the smoking article so that the amount of ascorbic acid consumed by the smoker is in direct relation to the number of cigarettes smoked.
A most important object of my invention is that the smoker cannot fail to remember to take this ascorbic acid supplementation before smoking the cigarette, cigar or other smoking article because the particular construction of the combination makes it necessary to remove the as corbic acid-containing material before the article can be smoked.
The drawing attached to this specification illustrates some of the means for accomplishing the purposes of this invention. FIGURE 1 is a side view of a cigarette, partly in section and showing the invention as applied to a recessed filter cigarette. FIGURE 2 is a view similar to FIGURE 1 but illustrating a form of the invention applied to a non-recessed filter cigarette or a non-filter cigarette or cigar. FIGURE 3 is a view similar to FIG- URE 1, but showing an edible tablet inserted in the end of a filter (or non-filter) cigarette. FIGURE 4 is a view similar to FIGURE 1, but showing an edible tablet inserted in the end of a recessed filter cigarette. FIGURE 5 is a view similar to FIGURE 1, but showing a recessed filter cigarette with the end stuffed with an edible ascorbic acid fluff. FIGURE 6 is a view similar to FIGURE 1, but showing a still further modification.
In FIGURE 1 there is shown the invention as applied to a recessed filter type cigarette. The outside membrane, 10, forms the wall of the cigarette; the recessed filter, 11, defines a cavity at the end of said cigarette. This cavity contains granules of a pharmaceutical confection contain ing ascorbic acid. The ascorbic acid containing material, 12, is a palatable mixture which may be prepared by mixing ascorbic acid and a sweetening agent such as sugar or synthetic sweeteners. If necessary to increase the bulk and aid in granulation of the powders, some inert filling material such as mannitol may be added. This mixture is granulated to obtain the free-flowing dry granules which being water soluble, will dissolve readily in the saliva when taken into the mouth. A snug cover, 13, retains the granules in the cavity. In use cover, 13, is removed and the cigarette end is inverted into the mouth to permit the granules to fall upon the tongue. After dissolution in the saliva it is then swallowed. The cigarette is then smoked in the normal manner.
In FIGURE 2 there is shown another embodiment of the invention suitable for cigarettes or cigars. The figure shows a cigarette with the month end covered or capped with a removable cover, 17. This cover is prepared from an edible sheet material containing the desired dosage of ascorbic acid. It may also contain sweetening or flavoring agents to make the ingestion of the edible sheet material more palatable. The edible sheet material can be prepared by drying a solution of an edible film forming agent such as carboxy methyl cellulose or other water soluble gums or polyvinylpyrrolidone or proteinaceous film forming materials like egg albumen, soluble caseinor mixtures thereof. The ascorbic acid may be dissolved in the solution of the film forming agent before drying on a fiat surface to obtain the soluble, edible, ascorbic acid-containing sheet material. In use the smoker removes the edible cover, 17, and allows it to dissolve in the mouth and in this Way imbibes the requisite dosage of ascorbic acid. The cigarette or cigar may then be smoked in the usual fashion.
In FIGURES 3 and 4 there are illustrated cigarettes constructed to accommodate a shaped tablet containing the proper dosage of ascorbic acid and any flavoring or sweetening agents to make them more palatable. In FIGURE 3 the tablet, 30, is inserted into the mouth end of a filter cigarette by means of the inwardly projecting tip, 32. In FIGURE 4 the shaped tablet, 49, is fitted like a plug into the cavity, 4 1, formed at the mouth end of a recessed filter cigarette, 42. In each case the smoker removes the tablet from the cigarette with his teeth or lips and either chews or lets the tablet dissolve in his mouth. The cigarette is then lit and smoked as usual.
FIGURE 5 shows the application of edible filamentous fiufi? material containing ascorbic acid in conjunction with a recessed filter type cigarette. This ascorbic acid-containing fluff, 50, which is stuffed into the cavity, 511, at the recessed filter end of the cigarette, 52. This fluff is prepared by the centrifugal methods commonly used to prepare cotton candy. The smoker merely snags the ascorbic acid flufi? with his teeth and removes it to his mouth where it dissolves and is swallowed. In this Way he replaces the ascorbic acid that will be lost during smoking.
In FIGURE 6 there is shown a filter cigarette, 60, with a cavity, 6 1, in the filter which may be filled with ascorbic acid-containing granules as in FIGURE 1 or ascorbic acid containing fluff as in FIGURE 5 or with an ascorbic acidcontaining tablet as in FIGURE 4.
These drawings illustrate some of the means for accomplishing the purposes of this invention. It is not intended that the scope of this patent be limited by the forms shown. Many variations are possible in constructional details which can be made by those skilled in the art without departing from the invention as defined in the claims.
I claim:
'1. An improved elongated smokable tobacco product comprising a cylindrical body of tobacco having a caplike member surrounding at least one end thereof and in slideable engagement therewith, said cap-like member being formed of an edible, water-soluble sheet-forming material containing a mass of ascorbic acid at least equal in Weight to the amount of ascorbic acid lost in the human body in the smoking of said tobacco product.
2. In combination with an elongated smoking tobacco product a mass of ascorbic acid at least equal in weight to the amount of ascorbic acid lost by the human body in smoking said tobacco product, located adjacent one end thereof and means connecting said mass of ascorbic acid to said tobacco product in such a way that said mass may be removed from said tobacco product without destruction thereof, said mass of ascorbic acid and its connecting means completely obstructing one end of said tobacco product, said means for connecting said ascorbic acid to said tobacco product comprising an edible sheath surrouding one end of said tobacco product and said mass of ascorbic acid being disposed within said sheath.
3. An elongated smoking tobacco product comprising a tubular casing enclosing a charge of smoking tobacco, said tubular casing extending at one end past said charge of tobacco whereby a recess is formed in said end, a solid cylindrical tablet located in said recess in frictional engagement with the walls thereof substantially obstructing said end and extending outwardly from the end of said recess in such manner that its removal before smoking said tobacco product is facilitated; said tablet being edible and comprising a mass of ascorbic acid at least equal in weight 5 6 to the amount of ascorbic acid lost by the human body FOREIGN PATENTS in smoking said tobacco product. 5 0 12/1947 France References Cited by the Examiner OTHER REFERENCES UNITED STATES PATENTS 5 Landc: APC Publication 261,049, of May 11, 1943, 515,774 3/1894 Hotz 1319 131-17. 1,926,564 9/1933 Sharp 131-4 2,804,078 8/ 1957 Safiir 13110 SAMUEL KOREN, Primary Examiner. 2,965,496 12/1960 d 20647 2,998,820 9/1961 if 10 MELVIN D. REIN, Examiner.
Claims (1)
1. AN IMPROVED ELONGATED SMOKABLE TOBACCO PRODUCT COMPRISING A CYLINDRICAL BODY OF TOBACCO HAVING A CAPLIKE MEMBER SURROUNDING AT LEAST ONE END THEREOF AND IN SLIDEABLE ENGAGEMENT THEREWITH, SAID CAP-LIKE MEMBER BEING FORMED OF AN EDIBLE, WATER-SOLUBLE SHEET-FORMING MATERIAL CONTAINING A MASS OF ASCORBIC ACID AT LEAST EQUAL IN WEIGHT TO THE AMOUNT OF ASCORBIC ACID LOST IN THE HUMAN BODY IN THE SMOKING OF SAID TOBACCO PRODUCT.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US381091A US3244180A (en) | 1964-07-08 | 1964-07-08 | Smoking article combination |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US381091A US3244180A (en) | 1964-07-08 | 1964-07-08 | Smoking article combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3244180A true US3244180A (en) | 1966-04-05 |
Family
ID=23503615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US381091A Expired - Lifetime US3244180A (en) | 1964-07-08 | 1964-07-08 | Smoking article combination |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3244180A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3771535A (en) * | 1972-01-07 | 1973-11-13 | Artmor Services Inc | Disposable cigarette holders |
| US3789840A (en) * | 1971-07-27 | 1974-02-05 | R Rosenblatt | Device for assisting cigarette smokers to discontinue smoking |
| US3994305A (en) * | 1975-07-28 | 1976-11-30 | Hughes Lloyd M | Self-lighting cigarette having a protective cap |
| USRE30704E (en) * | 1977-07-29 | 1981-08-11 | Lloyd M. Hughes Enterprises, Inc. | Self-lighting cigarette having a protective cap |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US515774A (en) * | 1894-03-06 | Eugen hotz | ||
| US1926564A (en) * | 1931-12-19 | 1933-09-12 | Harry Ellsworth Smith | Cigarette |
| FR932560A (en) * | 1944-06-20 | 1948-03-25 | Device usable in the consumption of tobacco by combustion | |
| US2804078A (en) * | 1954-10-13 | 1957-08-27 | Jacob A Saffir | Filter type cigarettes |
| US2965496A (en) * | 1959-02-27 | 1960-12-20 | Paul E Serdar | Food package |
| US2998820A (en) * | 1959-05-01 | 1961-09-05 | Viola G Ades | Cigarette |
-
1964
- 1964-07-08 US US381091A patent/US3244180A/en not_active Expired - Lifetime
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US515774A (en) * | 1894-03-06 | Eugen hotz | ||
| US1926564A (en) * | 1931-12-19 | 1933-09-12 | Harry Ellsworth Smith | Cigarette |
| FR932560A (en) * | 1944-06-20 | 1948-03-25 | Device usable in the consumption of tobacco by combustion | |
| US2804078A (en) * | 1954-10-13 | 1957-08-27 | Jacob A Saffir | Filter type cigarettes |
| US2965496A (en) * | 1959-02-27 | 1960-12-20 | Paul E Serdar | Food package |
| US2998820A (en) * | 1959-05-01 | 1961-09-05 | Viola G Ades | Cigarette |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3789840A (en) * | 1971-07-27 | 1974-02-05 | R Rosenblatt | Device for assisting cigarette smokers to discontinue smoking |
| US3771535A (en) * | 1972-01-07 | 1973-11-13 | Artmor Services Inc | Disposable cigarette holders |
| US3994305A (en) * | 1975-07-28 | 1976-11-30 | Hughes Lloyd M | Self-lighting cigarette having a protective cap |
| USRE30704E (en) * | 1977-07-29 | 1981-08-11 | Lloyd M. Hughes Enterprises, Inc. | Self-lighting cigarette having a protective cap |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3339558A (en) | Smoking article and filter therefor containing vitamin a | |
| US4774971A (en) | Cigarette substitute | |
| DK173353B1 (en) | Capsule comprising a nicotine-containing liquid medium for oral ingestion | |
| US5783207A (en) | Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine | |
| KR100283038B1 (en) | Cigarette filter for administering taurine by inhalation | |
| US6583160B2 (en) | Nicotine therapy method and oral carrier for assuaging tobacco-addiction | |
| US7845358B2 (en) | Method for controlling, reducing, and quitting smoking | |
| KR100370340B1 (en) | Tobacco Substitute Composition | |
| IE72523B1 (en) | Nicotine oral delivery device | |
| US20080166395A1 (en) | Article for delivering substrates to the oral cavity | |
| US20100200008A1 (en) | E-Cigarette With Vitamin Infusion | |
| US4655231A (en) | Snuff and preparation thereof | |
| EA002711B1 (en) | Tobacco products with vitamin e | |
| US20050034738A1 (en) | Chewing tobacco substitute containing nicotine | |
| MX2012009586A (en) | WHITE GELATINE PADS WITH NICOTINE. | |
| US20060162732A1 (en) | Method for making a nicotine toothpick | |
| US3244180A (en) | Smoking article combination | |
| EP0745380A2 (en) | Tobacco substitute | |
| US3439685A (en) | Method for breaking the cigarette habit | |
| BRPI0711996A2 (en) | Pharmaceutical preparation in the form of a sheet, Use of the pharmaceutical preparation, Use of a combination of active agents, Method for the therapeutic treatment of an individual and Method for the production of a dosage form | |
| US20060112965A1 (en) | Chewing tobacco substitute containing cotinine | |
| US20080017205A1 (en) | Method and Device for Releasing Flavor and Odor Substances | |
| Rosenberg | An investigation into the effect on cigarette smoking of a new anti-smoking chewing gum | |
| EP0450253B1 (en) | Means for breaking the habitual use of tobacco | |
| US3851069A (en) | Tobacco flavored candy |